#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	18880	16S	1529	1529	99.93	16S.l6.c4.ctg.1	2237	832.4	0	.	n	.	0	C1450T	SNP	1450	1450	C	1789	1789	T	1049	T,C	988,7	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	18880	16S	1529	1529	99.93	16S.l6.c4.ctg.1	2237	832.4	1	SNP	n	C1184T	0	.	.	1184	1184	C	1523	1523	C	1028	C	1000	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	35522	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3565	982.9	0	.	n	.	0	G1337A	SNP	1337	1337	G	1686	1686	A	1156	A,G	1117,2	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	35522	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3565	982.9	0	.	n	.	0	T1971C	SNP	1971	1971	T	2320	2320	C	1086	C	1043	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	35522	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3565	982.9	1	SNP	n	A2045G	0	.	.	2045	2045	A	2394	2394	A	1133	A,C	1092,1	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	35522	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3565	982.9	1	SNP	n	C2597T	0	.	.	2597	2597	C	2946	2946	C	1103	C	1074	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_O_01412c	folP.WHO_O_01412c	1	1	27	2492	folP	855	855	100.0	folP.l15.c4.ctg.1	1511	163.0	1	SNP	p	R229S	1	.	.	685	687	AGC	1036	1038	AGC	258;259;258	A;G;C	247;248;244	folP.WHO_O_01412c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	6656	gyrA	2751	2751	99.96	gyrA.l15.c4.ctg.1	3379	194.0	1	SNP	p	S91F	1	.	.	271	273	TTC	638	640	TTC	215;213;213	T;T,C;C	211;206,1;207	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	6656	gyrA	2751	2751	99.96	gyrA.l15.c4.ctg.1	3379	194.0	1	SNP	p	G95N	0	.	.	283	285	GGC	650	652	GGC	209;207;210	G;G,A;C	205;200,1;205	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	6656	gyrA	2751	2751	99.96	gyrA.l15.c4.ctg.1	3379	194.0	1	SNP	p	D95G	1	.	.	283	285	GGC	650	652	GGC	209;207;210	G;G,A;C	205;200,1;205	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_X_01389	mtrR.WHO_X_01389	1	1	27	2300	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1376	165.1	1	SNP	p	G45D	0	.	.	133	135	GGC	467	469	GGC	276;272;277	G;G;C	270;267;268	mtrR.WHO_X_01389:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	1146	mtrR_promoter	250	250	99.6	mtrR_promoter.l6.c30.ctg.1	1077	105.1	0	.	n	.	0	A197.	DEL	197	197	A	626	626	A	280	A	272	.	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	5658	parC	2304	2304	99.87	parC.l15.c4.ctg.1	2873	194.3	0	.	p	.	0	I384V	NONSYN	1150	1152	ATC	1452	1454	GTC	229;228;230	G;T;C	219;216;218	.	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	5658	parC	2304	2304	99.87	parC.l15.c4.ctg.1	2873	194.3	1	SNP	p	D86N	0	.	.	256	258	GAC	558	560	GAC	221;222;223	G;A;C	215;205;217	parC.WHO_V_00204c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	5658	parC	2304	2304	99.87	parC.l15.c4.ctg.1	2873	194.3	1	SNP	p	S87R	1	.	.	259	261	CGT	561	563	CGT	225;225;225	C;G;T	220;220;218	parC.WHO_V_00204c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	5658	parC	2304	2304	99.87	parC.l15.c4.ctg.1	2873	194.3	1	SNP	p	R87W	0	.	.	259	261	CGT	561	563	CGT	225;225;225	C;G;T	220;220;218	parC.WHO_V_00204c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	5658	parC	2304	2304	99.87	parC.l15.c4.ctg.1	2873	194.3	1	SNP	p	R87I	0	.	.	259	261	CGT	561	563	CGT	225;225;225	C;G;T	220;220;218	parC.WHO_V_00204c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	5658	parC	2304	2304	99.87	parC.l15.c4.ctg.1	2873	194.3	1	SNP	p	S88P	0	.	.	262	264	TCC	564	566	TCC	225;227;226	T;C;C	219;219;218	parC.WHO_V_00204c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	539	5228	parE	1986	1986	99.95	parE.l15.c4.ctg.1	2609	197.6	0	.	p	.	0	R340C	NONSYN	1018	1020	CGC	1297	1299	TGC	242;239;241	T,C,G;G;C	234,2,1;236;237	.	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	539	5228	parE	1986	1986	99.95	parE.l15.c4.ctg.1	2609	197.6	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1507	1509	GGC	280;279;279	G;G;C	268;268;267	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.12.001	penA.12.001	1	1	27	5256	penA	1749	1749	99.94	penA.l6.c17.ctg.1	2352	220.3	1	SNP	p	A311V	0	.	.	931	933	GCA	1238	1240	GCA	271;273;276	G,T;C;A	260,1;261;265	penA.12.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	5256	penA	1749	1749	99.94	penA.l6.c17.ctg.1	2352	220.3	1	SNP	p	I312M	0	.	.	934	936	ATC	1241	1243	ATC	280;277;280	A;T;C	268;264;265	penA.12.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	5256	penA	1749	1749	99.94	penA.l6.c17.ctg.1	2352	220.3	1	SNP	p	V316P	0	.	.	946	948	GTG	1253	1255	GTG	270;266;269	G,T;T;G	259,1;250;256	penA.12.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	5256	penA	1749	1749	99.94	penA.l6.c17.ctg.1	2352	220.3	1	SNP	p	V316T	0	.	.	946	948	GTG	1253	1255	GTG	270;266;269	G,T;T;G	259,1;250;256	penA.12.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	5256	penA	1749	1749	99.94	penA.l6.c17.ctg.1	2352	220.3	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1757	1759	ACC	247;246;247	A;C;C	231;235;237	penA.12.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	5256	penA	1749	1749	99.94	penA.l6.c17.ctg.1	2352	220.3	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1811	1813	GCG	242;241;246	G,A;C,G;G,C	231,1;214,1;233,1	penA.12.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	5256	penA	1749	1749	99.94	penA.l6.c17.ctg.1	2352	220.3	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1811	1813	GCG	242;241;246	G,A;C,G;G,C	231,1;214,1;233,1	penA.12.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	5256	penA	1749	1749	99.94	penA.l6.c17.ctg.1	2352	220.3	1	SNP	p	G543S	0	.	.	1627	1629	GGC	1934	1936	GGC	228;225;223	G;G;C,T	224;219;214,1	penA.12.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	5256	penA	1749	1749	99.94	penA.l6.c17.ctg.1	2352	220.3	1	SNP	p	G546S	0	.	.	1636	1638	GGC	1943	1945	GGC	221;218;217	G,A;G;C,A,T	207,1;206;202,1,1	penA.12.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	5256	penA	1749	1749	99.94	penA.l6.c17.ctg.1	2352	220.3	1	SNP	p	P552S	1	.	.	1654	1656	TCG	1961	1963	TCG	211;210;207	T,G,C;C,G;G,C	130,30,1;176,3;185,1	penA.12.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	7470	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3303	223.3	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1754	1756	CCG	271;271;269	C;C;G,C	252;261;254,1	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	3050	porA	1146	1146	99.56	porA.l6.c4.ctg.1	1939	154.7	0	.	p	.	0	M83fs	FSHIFT	247	247	A	587	587	C	217	C	202	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3620	porB1b	1047	1047	99.24	porB1b.l15.c17.ctg.1	1451	244.7	0	.	p	.	0	N38E	NONSYN	112	114	AAT	376	378	GAA	282;280;280	G;A;A	275;273;272	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3620	porB1b	1047	1047	99.24	porB1b.l15.c17.ctg.1	1451	244.7	0	.	p	.	0	N134D	NONSYN	400	402	AAT	664	666	GAT	256;257;259	G,A;A;T,G	246,1;248;247,1	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3620	porB1b	1047	1047	99.24	porB1b.l15.c17.ctg.1	1451	244.7	0	.	p	.	0	P175S	NONSYN	523	525	CCA	787	789	TCA	261;269;267	T,C;C,A;A	251,1;260,1;261	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3620	porB1b	1047	1047	99.24	porB1b.l15.c17.ctg.1	1451	244.7	0	.	p	.	0	F215S	NONSYN	643	645	TTT	907	909	TCT	287;286;286	T;C,A;T	281;275,1;283	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3620	porB1b	1047	1047	99.24	porB1b.l15.c17.ctg.1	1451	244.7	0	.	p	.	0	A218V	NONSYN	652	654	GCC	916	918	GTC	279;280;279	G,A;T;C,T	270,1;271;270,1	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3620	porB1b	1047	1047	99.24	porB1b.l15.c17.ctg.1	1451	244.7	0	.	p	.	0	E328A	NONSYN	982	984	GAA	1246	1248	GCA	286;284;284	G;C,A;A	270;268,2;270	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3620	porB1b	1047	1047	99.24	porB1b.l15.c17.ctg.1	1451	244.7	1	SNP	p	G120K	1	.	.	358	360	AAG	622	624	AAG	269;270;271	A;A;G	262;262;262	porB1b.WHO_V_02265c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3620	porB1b	1047	1047	99.24	porB1b.l15.c17.ctg.1	1451	244.7	1	SNP	p	A121D	1	.	.	361	363	GAC	625	627	GAC	268;267;266	G,A;A,G,C;C,A	260,1;257,1,1;258,1	porB1b.WHO_V_02265c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3620	porB1b	1047	1047	99.24	porB1b.l15.c17.ctg.1	1451	244.7	1	SNP	p	D121N	0	.	.	361	363	GAC	625	627	GAC	268;267;266	G,A;A,G,C;C,A	260,1;257,1,1;258,1	porB1b.WHO_V_02265c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	12974	rpoB	4179	4179	100.0	rpoB.l15.c4.ctg.1	4934	258.8	1	SNP	p	H553N	1	.	.	1657	1659	AAT	2067	2069	AAT	266;266;267	A,C;A;T	259,1;259;258	rpoB.WHO_M_02157:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1504	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1133	130.6	1	SNP	p	V57M	1	.	.	169	171	ATG	613	615	ATG	306;307;307	A,G;T;G	295,1;297;295	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
